Skip to main content
Equibles

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in AKBA — Akebia Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$672,395
-$331,350 QoQ
Shares Held
589,821
-18.3% QoQ
Ownership
0.213%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 170 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Derivatives in AKBA

reported options exposure · as of Jun 30, 2026
CallValue
$279,072
CallShares
244,800
PutValue
$304,722
PutShares
267,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $270,923,179 across 52 Drug Manufacturers - Specialty & Generic names. AKBA ranks #25 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,504,358 $108,103,165
2 UTHR
UNITED THERAPEUTICS Corp
 88,579 $47,994,759
3 LQDA
Liquidia Corp
 471,067 $37,558,171
4 BCRX
Biocryst Pharmaceuticals Inc
 1,195,651 $11,956,510
5 PRGO
PERRIGO Co plc
 1,149,496 $11,943,263
6 HROW
Harrow, Inc.
 190,116 $8,074,226
7 VTRS
Viatris Inc
 295,261 $4,688,744
8 TLRY
Tilray Brands, Inc.
 1,021,777 $4,587,778

All Filings in AKBA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $279,072 244,800
2026-06-30 $304,722 267,300
2026-06-30 $672,395 589,821
2026-03-31 $258,123 185,700
2026-03-31 $274,247 197,300
2026-03-31 $1,003,745 722,119
2025-12-31 $297,045 184,500
2025-12-31 $105,133 65,300
2025-12-31 $1,042,817 647,713
2025-09-30 $329,238 120,600
2025-09-30 $137,046 50,200
2025-09-30 $1,344,071 492,334
2025-06-30 $2,880,521 791,352
2025-06-30 $222,404 61,100
2025-06-30 $283,556 77,900
2025-03-31 $298,752 155,600
2025-03-31 $95,808 49,900
2025-03-31 $1,319,575 687,279
2024-12-31 $179,550 94,500
2024-12-31 $1,113,584 586,097
2024-09-30 $142,824 108,200
2024-09-30 $130,548 98,900
2024-09-30 $217,232 164,570
2024-06-30 $161,466 158,300
2024-06-30 $440,232 431,600
2024-06-30 $253,788 248,813
2024-03-31 $1,272,216 695,200
2024-03-31 $361,791 197,700
2024-03-31 $3,225,217 1,762,414
2023-12-31 $187,488 151,200
2023-12-31 $2,677,611 2,159,364
2023-12-31 $262,880 212,000
2023-09-30 $154,584 135,600
2023-09-30 $170,886 149,900
2023-09-30 $855,502 750,441
2023-06-30 $297,495 325,132
2023-06-30 $55,174 60,300
2023-06-30 $112,087 122,500
2023-03-31 $75,320 134,500
2023-03-31 $31,696 56,600
2023-03-31 $208,047 371,514
2022-12-31 $12,405 21,500
2022-12-31 $35,716 61,900
2022-12-31 $304,169 527,158
2022-09-30 $19,750 62,500
2022-09-30 $26,038 82,400
2022-09-30 $146,181 462,600
2022-06-30 $34,770 98,500
2022-06-30 $32,228 91,300
2022-06-30 $186,895 529,450